A446600 Stock Overview
KAI Biotech Co., LTD. manufactures and sells radiopharmaceuticals, dementia diagnosis drugs, and liver cancer treatment drugs.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
KAI Biotech Co., LTD. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩6,340.00 |
| 52 Week High | ₩23,000.00 |
| 52 Week Low | ₩6,340.00 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | -56.22% |
| 1 Year Change | -71.38% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -71.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| A446600 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 0% | 1.0% | 0.6% |
| 1Y | -71.4% | 10.4% | 6.9% |
Return vs Industry: A446600 underperformed the KR Pharmaceuticals industry which returned 10.4% over the past year.
Return vs Market: A446600 underperformed the KR Market which returned 6.9% over the past year.
Price Volatility
| A446600 volatility | |
|---|---|
| A446600 Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 4.5% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in KR Market | 11.7% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A446600's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine A446600's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | www.kaibiotech.com |
KAI Biotech Co., LTD. manufactures and sells radiopharmaceuticals, dementia diagnosis drugs, and liver cancer treatment drugs. The company is based in Jeonju, South Korea.
KAI Biotech Co., LTD. Fundamentals Summary
| A446600 fundamental statistics | |
|---|---|
| Market cap | ₩6.22b |
| Earnings (TTM) | ₩0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A446600 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A446600 income statement (TTM) | |
|---|---|
| Revenue | ₩0 |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩0 |
| Other Expenses | ₩0 |
| Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A446600 perform over the long term?
See historical performance and comparison